Blueshift Asset Management, LLC Biocryst Pharmaceuticals Inc Transaction History

Blueshift Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$11.56 - $19.76 $368,879 - $630,541	-31,910 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$11.18 - $15.46 $126,870 - $175,440	11,348 Added 55.19%	31,910 $442,000
Q3 2021 Nov 12, 2021	BUY	$14.21 - $17.65 $292,186 - $362,919	20,562 New	20,562 $295,000
Q2 2021 Aug 13, 2021	SELL	$9.5 - $17.24 $547,722 - $993,972	-57,655 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$7.37 - $13.61 $424,917 - $784,684	57,655 New	57,655 $586,000

257

173M

397K

444K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.47B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.